Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | DYRK3 | O43781 | 5/20 | 0.60 |
| ▸ | PIM1 | P11309 | 5/20 | 0.60 |
| ▸ | CSNK2A2 | P19784 | 5/20 | 0.60 |
| ▸ | CSNK2B | P67870 | 5/20 | 0.60 |
| ▸ | CSNK2A1 | P68400 | 5/20 | 0.60 |
| ▸ | DYRK1A | Q13627 | 5/20 | 0.60 |
| ▸ | CSNK2A3 | Q8NEV1 | 5/20 | 0.60 |
| ▸ | DYRK2 | Q92630 | 5/20 | 0.60 |
| ▸ | DYRK1B | Q9Y463 | 5/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | GPR18 | Q14330 | 2/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CLK1 | P49759 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30363327 | 1.00 | MAPT (0.63) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL30363333 | 0.87 | MAPT (0.58) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL26093496 | 0.87 | MAPT (0.58) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL26095879 | 0.80 | MAPT (0.56) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL26096202 | 0.80 | MAPT (0.58) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL30363342 | 0.79 | MAPT (0.57) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL26095459 | 0.79 | MAPT (0.57) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL30363453 | 0.77 | MAPT (0.62) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL26092928 | 0.77 | MAPT (0.62) | MAPTGAADYRK3PIM1CSNK2A2 | |
| SCHEMBL30145012 | 0.75 | MAPT (0.56) | MAPTGAADYRK3PIM1CSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250340538-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | PERHA PHARMACEUTICALS (FR) | 2025-11-06 | — | — | US | disclosed |
| WO-2023072969-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | PERHA PHARMACEUTICALS (FR) | 2023-05-04 | — | — | WO | disclosed |
| EP-4173674-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | Perha Pharmaceuticals (FR) | 2023-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250340538-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | CLK1, CLK2, CLK3 | MAPT 330/4885GAA 4344/4885DYRK3 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.